Skip to main content
πŸ’Š Pharma Supply Chain AI Β· GxP Intelligence

API stockouts and batch failures
caught 30 days earlier.

Upload supplier records, batch data, or inventory reports. Get API risk scores, quality failure pattern detection, and supply chain alerts before CDSCO does β€” in under 30 seconds.

<24 hrs

Batch Rejection Detection

Pattern detected by AI

+30 dayswarning

Supply Risk Lead Time

Before disruption hits

0–100

API Supplier Risk Score

Per supplier, per API

12 daysearly

Inventory Imbalance Alert

Before stockout

Real Pain β†’ AI Solves It

Your team faces these every week.
OpsOracle names them and fixes them.

Actual AI output from real pharmaceutical supply chain data. Upload your report and get this analysis in under 30 seconds.

The Pain

One of our critical API suppliers is sole-source. Any disruption stops 3 formulations. Procurement has no visibility into their risk.

Raw data signal

Supplier: ChemIndia Ltd | API: Paracetamol API | Lead time: 45 days | Last delivery: On time | Dependency: 100% | Inventory: 22 days stock | MOQ: 2000 kg

OpsOracle AI Output

91% Risk β€” CRITICAL β€” Single-Source API Exposure

ChemIndia Ltd is sole-source for Paracetamol API with only 22 days of buffer stock β€” below the 30-day minimum for uninterrupted production. 45-day lead time + 22-day inventory = 0-day safety window if any disruption occurs. 3 formulations stop simultaneously. This is a regulatory and revenue risk: stockout = batch failure + potential recall.

[THIS WEEK] Action

Emergency: qualify alternate API supplier this quarter. Increase safety stock to 60 days (4000 kg immediate purchase). Negotiate vendor-managed inventory agreement with ChemIndia to gain 14-day early warning on supply delays. File alternate source with CDSCO within 90 days.

Expected impact: Prevent 3-formulation production halt worth β‚Ή1.2–2.4Cr/month in lost output. Eliminate CDSCO non-compliance risk from supply disruption.

The Pain

Batch rejection rate jumped from 1.2% to 4.8% this month. QA is investigating but no patterns found yet.

Raw data signal

Batch #1–20: Rejection rate 1.2% | Batch #21–40: Rejection rate 3.1% | Batch #41–55: Rejection rate 4.8% | Rejected: Dissolution failure 7 batches | API lot changed: Batch #22 | Temperature excursion: Cold room C batch 38–40

OpsOracle AI Output

86% Risk β€” CRITICAL β€” Quality Deterioration Pattern

Rejection rate is escalating in 3 discrete steps β€” not random. Two correlated events: (1) API lot change at Batch #22 coincides with first rejection spike; (2) Temperature excursion in Cold Room C covers Batches 38–40, the highest rejection cluster. Dissolution failures are consistent with either API potency variation or stability compromise from temperature breach.

[THIS WEEK] Action

QA to compare API CoA across lot pre/post Batch #22 β€” focus on particle size distribution and dissolution profile. Cold Room C: audit temperature logger for Batches 38–40, quarantine if excursion confirmed, test retained samples. Report to QP before next batch release.

Expected impact: Prevent further β‚Ή48L in rejected batch losses this month. Avoid regulatory trigger if pattern continues β€” 5% batch rejection typically triggers CDSCO audit.

The Pain

We have 6 months of finished goods inventory for Product X but stockout risk on Product Y which shares the same packing line.

Raw data signal

Product X: 180 days inventory | Monthly demand: 8000 units | Packing line utilisation: 62% for X. Product Y: 12 days inventory | Monthly demand: 22,000 units | Packing line: shared with X | Lead time: 35 days

OpsOracle AI Output

73% Risk β€” HIGH β€” Inventory Imbalance Crisis

Product X holding 180 days stock (6Γ— optimal 30-day buffer) while Product Y has only 12 days β€” below critical threshold given 35-day replenishment lead time. With shared packing line at 62% utilisation on X, Product Y is being crowded out. At current schedule, Product Y stockout in 12 days before any new production run completes.

[THIS WEEK] Action

Immediate: reduce Product X packing schedule to 20% of line capacity. Dedicate 80% to Product Y for next 21 days to build buffer to 45 days. Commercial team to review Product X sales velocity β€” 180-day stock at 8K units/month suggests demand forecast error.

Expected impact: Prevent Product Y stockout (β‚Ή44L/month revenue at risk). Free β‚Ή28L in Product X working capital by correcting over-production.

Analyze Your pharmaceutical supply chain Data Free β†’

14-day Pro trial Β· No credit card Β· Results in 30 seconds

Upload pharma data β€” get supply chain intelligence in 30 seconds

🧠

AGI Pain Solver

Powered by OpsOracle AI Β· Streaming action plan

Ask the Pharma AGI anything

API supplier risk, batch quality patterns, CDSCO compliance β€” instant AI answers

🧠

AGI Chat Agent

Multi-turn Β· tool access Β· real data

Ask anything about your operations

AI looks up your real data before answering